First International Moxifloxacin Symposium

Berlin, 1999

  • Lionel Mandell

Table of contents

  1. Front Matter
    Pages I-XIII
  2. Introduction to the Symposium

    1. Lionel Mandell
      Pages 1-3
  3. Antimicrobial Chemotherapy

    1. Front Matter
      Pages 5-5
    2. John David Williams
      Pages 7-11
    3. Hartmut Lode
      Pages 12-18
  4. Pre-clinical

  5. Pharmacology

  6. Clinical Needs in the Millenium

  7. Round Table Discussion

    1. Front Matter
      Pages 181-181
    2. Lionel Mandell
      Pages 183-183
    3. Lionel Mandell
      Pages 184-188
    4. Lionel Mandell
      Pages 189-190

About these proceedings


The proceedings of this symposium focus on the new and exciting fluoroquinolone Moxifloxacin. Physicians/scientists from around the world have contributed to this effort and the information in these proceedings has been organized as follows: Part I: Antimicrobial Chemotherapy Part II: Preclinical Microbiology Part III: Pharmacology Part IV: Clinical Needs in the Millenium Part V: Round Table Discussion It is hoped that the reader will gain an appreciation of the various basic and clinical issues pertaining to the fluoroquinolones in general and moxifloxacin in particular and the role of this agent in the management of respiratory tract infections.


absorption antimicrobial biology chemotherapy distribution dynamics infection kinetics metabolism pharmacokinetics pharmacology resistance safety therapy toxicity

Editors and affiliations

  • Lionel Mandell
    • 1
  1. 1.Division of Infectious Diseases Henderson General HospitalMcMaster UniversityHamiltonCanada

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 2000
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-64081-0
  • Online ISBN 978-3-642-59681-0
  • Buy this book on publisher's site